You are here: Home » Companies » News
Facebook, Twitter to defend companies against charges of bias in elections
Bullish alumina prices to hike Vedanta's metal cost by 10%
Business Standard

Rising API prices to hit drug firms' profit by 300-500 bps in 2-3 quarters

In the past few months, the prices of APIs from China have gone up in the range of 15-80 per cent, amid a crackdown by the local government on industries allegedly polluting the environment

Topics
Pharma Industry  |  Pharmaceutical Companies  |  Healthcare

Samreen Ahmad  |  Bengaluru 



Representative Image
Representative Image

Increasing prices of active pharmaceutical ingredients (APIs) from China are likely to hit the margins of Indian . According to India Ratings and Research (Ind-Ra), this could hit the operating profit margins of the domestic pharma by as much as 300-500 basis points in the next two-three quarters of the current financial year.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.


We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Wed, September 05 2018. 12:59 IST

.